Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks how CAR-T therapy impacts Seniors' daily lives

NCT ID NCT04300998

Recruiting now Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes older patients (60+) receiving standard CAR-T therapy for blood cancers. Researchers track how treatment affects daily activities, thinking skills, and overall quality of life. No extra treatments are given—just careful monitoring to learn more about patient experiences.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand how CAR-T therapy affects older patients' daily lives and thinking abilities.
What could go wrong
This is an observational study, not a treatment trial. It may not lead to direct improvements in care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DLBCL NOS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

B-cell neoplasm B-cell non-Hodgkin lymphoma diffuse large B-cell lymphoma high grade B-cell lymphoma lymphoma plasma cell myeloma plasma cell neoplasm refractory hematologic cancer refractory plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DLBCL NOS HIGH-GRADE B-CELL LYMPHOMA LYMPHOMA LYMPHOMA, B-CELL MULTIPLE MYELOMA REFRACTORY B-CELL LYMPHOMA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.